Results 121 to 130 of about 37,359 (216)
A novel series of 1,5‐dihydro‐[1,2,4]triazolo[4,3‐a]pyrimidines (5a–g) is synthesized and evaluated as potential CDK4 inhibitors. Compounds 5c and 5d exhibit strong cytotoxicity toward HepG2 and MCF‐7 cells with IC50 ≈ 1–2 µM, comparable to doxorubicin.
Tariq Z. Abolibda +7 more
wiley +1 more source
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer. [PDF]
Fabi A +17 more
europepmc +1 more source
Molecular dynamics analysis of novel statin analogs shows that binding induces superior stabilization of HMG‐CoA reductase. As shown by the solvent‐accessible surface area profile, ligand‐induced rigidity offers a new, effective strategy for drug design. Cardiovascular diseases remain a leading cause of global mortality.
Yoshua B. Mtulo +4 more
wiley +1 more source
Continuing Professional Development – Radiation Therapy
Journal of Medical Radiation Sciences, EarlyView.
wiley +3 more sources
CKAAKN peptide-conjugated long-circulating nanoliposomes for the targeted delivery of oridonin to pancreatic cancers. [PDF]
Zhang F +9 more
europepmc +1 more source
New pyrido[2,3‐d]azolopyrimidinones were synthesized and evaluated as potent EGFR‐targeted anticancer leads. Molecular docking and cytotoxicity studies revealed strong receptor binding and submicromolar activity, highlighting this scaffold as a promising framework for future targeted drug development.
Sobhi M. Gomha +6 more
wiley +1 more source
Development of a competitive immunoassay platform for quantifying the oligonucleotide products of nucleotide excision repair in UV-irradiated cells. [PDF]
Kim GH +4 more
europepmc +1 more source
Continuing Professional Development — Medical Imaging
Journal of Medical Radiation Sciences, EarlyView.
wiley +3 more sources
Through molecular engineering, an unconventional chiral 2D platform based on covalently functionalized 2D germanane achieved magneto‐controlled spin‐dependent electron transport, which can be further tuned through the enantiomeric configuration of the chiral ligand.
Yiming Lei +6 more
wiley +1 more source
CPD-1 can compensate for EGL-21 to process neuropeptides. [PDF]
Khawand DC, Clippinger AK, Ailion M.
europepmc +1 more source

